{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Updates and Approvals: 2018 in Review

Activity Steps

Purpose of Activity

The purpose of this learning activity is to provide information about six drugs that received FDA approval in 2018.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify the indications, mechanisms of action, and dosages for six drugs that were approved by the FDA in 2018.
  2. Recognize the adverse reactions, contraindications, warnings, and important nursing implications for these new drugs.
Price: $17.95


  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: NP1218A
Published: Dec 2018
Expires: 12/4/2020
Passing Score: 13/18 (72%)
Authors: Cortney Mospan, PharmD, BCACP, BCGP; Geoffrey Mospan, PharmD, BCPS; Emily Byland; William Blake Whitaker; Linda Xiong; Jordan Dunlap; Katherine Canupp